DFID 7811 South Sudan Integrated Community Case Management 2 Programme (ICCM2)

Tender description

The UK Department for International Development (DFID) is seeking to appoint a supplier to effectively manage and deliver the 'Integrated Community Case Management Phase 2 (ICCM2)' programme in South Sudan. DFID's mission is to help eradicate poverty in the world's poorest countries. The priority objective for DFID South Sudan - with the international community - is to support the peace, whilst recognising that prospects remain fragile and that even in a best case scenario, continued protection of and support to the most vulnerable (particularly youth, women and children) will be essential for years to come. The focus of the DFID South Sudan strategy is on sustaining high levels of humanitarian support and the provision of essential services, whilst looking for and supporting opportunities to embed peace, in areas where we have comparative advantage. The ICCM2 programme is part of the Essential Services portfolio. This programme will complement other areas of DFID health sector support in South Sudan such as the Health Pooled Fund programme and our humanitarian programmes. The programme will contribute to important UK Government manifesto commitments on malaria and nutrition, and will comply with the International Development Gender Equality Act (2014), in particular ensuring actions and services have meaningful and proportionate regard to the contribution our assistance is likely to make to reducing gender inequality or to gender-related differences in needs. DFID South Sudan is initiating a new 21 month (April 2017-December 2018) ICCM 2 programme to follow the current ICCM programme which ends in April 2016. The new contract is expected to start on 01 April though that date may be flexible depending on the contracting timescale. The programme impact will be to improve health care for children suffering from malaria, diarrhoea, pneumonia and severe acute malnutrition (SAM) and contribute to a reduction in the under-five child mortality rate in South Sudan. The outcome, of UK support, will be the provision of lifesaving care to an estimated 883,000 children under five with a minimum of: •1.3 million treatments for malaria with Artemisinin Combination Therapy (ACT) •1.1 million treatments for pneumonia with antibiotics •900,000 treatments for diarrhoea with Oral Rehydration Salts (ORS) and zinc •100,000 children treated for SAM with Ready-To-Use Therapeutic Foods (RUTFs) such as plumpy nut. There are no separate lots for this programme as the theory of change hinges on the ability of an overall supplier to coordinate the activities at a national level to create momentum for partner government capacity building. However, this does not preclude a consortium with a lead service provider